Mayur Ian Somaiya Tcr2 Therapeutics Inc. (TCRR) insider trading activity

Mayur Ian Somaiya is Chief Financial Officer of TCR2 THERAPEUTICS INC.. Currently has a direct ownership of 1,473 shares of TCRR, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2020, when has been sold 2,000 shares (Common Stock) at a price of $35.0 per share, resulting in proceeds of $70,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.47K

0% 3M change

0% 12M change

Total Value Held $0

Mayur Ian Somaiya Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 14 2020	SELL Open market or private sale	$70,000 $35.0 p/Share	2,000 Reduced 57.59%	1,473 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$11,760 $5.88 p/Share	2,000 Added 36.54%	3,473 Common Stock
Nov 17 2020	SELL Open market or private sale	$109,980 $30.0 p/Share	3,666 Reduced 71.34%	1,473 Common Stock
Nov 17 2020	BUY Exercise of conversion of derivative security	$11,760 $5.88 p/Share	2,000 Added 28.02%	5,139 Common Stock

Also insider at

NAMS

NewAmsterdam Pharma Co N.V.

Chief Financial Officer

MIS